
<!DOCTYPE html>
<html lang="en">
   <head>
      <!-- basic -->
      <meta charset="utf-8">
      <meta http-equiv="X-UA-Compatible" content="IE=edge">
      <!-- mobile metas -->
      <meta name="viewport" content="width=device-width, initial-scale=1">
      <meta name="viewport" content="initial-scale=1, maximum-scale=1">
      
      <!-- site metas -->
      <title>Data Sources</title>
      <meta name="viewport" content="width=device-width, initial-scale=1">
      <link rel="icon" href="images/logo.png" type="image/x-icon">
      <meta name="keywords" content="COVID-19, wastewater, measurement, monitoring, surveillance, public health, environmental monitoring, water analysis, viral RNA, SARS-CoV-2,SARS-nCoV-2, global, countries, data, analysis, pandemic, wastewater-based epidemiology, geo-map">
      <meta name="description" content="Data Sources of Visualizations">
      <meta name="author" content="Daniel Dynesius">
      <!-- bootstrap css -->
      <link rel="stylesheet" href="css/bootstrap.min.css">
      <!-- style css -->
      <link rel="stylesheet" href="css/style.css">
      <!-- Responsive-->
      <link rel="stylesheet" href="css/responsive.css">
      <!-- fevicon -->
      <link rel="icon" href="images/fevicon.png" type="image/gif" />
      <!-- Scrollbar Custom CSS -->
      <link rel="stylesheet" href="css/jquery.mCustomScrollbar.min.css">
      <!-- Tweaks for older IEs-->
      <link rel="stylesheet" href="https://netdna.bootstrapcdn.com/font-awesome/4.0.3/css/font-awesome.css">
      <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/fancybox/2.1.5/jquery.fancybox.min.css" media="screen">
      <style>
            @media (max-width: 767px) {
            /* Styles for screens smaller than 768px (mobile) */
            .menu-area-main {
                flex-direction: column;
            }
        
            .menu-area-main li {
                text-align: center;
            }
            }
    </style>      
      <!--[if lt IE 9]>
      <script src="https://oss.maxcdn.com/html5shiv/3.7.3/html5shiv.min.js"></script>
      <script src="https://oss.maxcdn.com/respond/1.4.2/respond.min.js"></script><![endif]-->
   </head>
   <!-- body -->
   <body class="main-layout">
      <!-- loader  -->
      <div class="loader_bg">
         <div class="loader"><img src="images/loading.gif" alt="#" /></div>
      </div>
      <!-- end loader --> 
      <!-- header -->
      <header>
         <!-- header inner -->
         <div class="header">
            <div class="head_top">
               <div class="container">
                  <div class="row">
                    <div class="col-xl-6 col-lg-6 col-md-6 col-sm-12">
                       <div class="top-box">
                        <ul class="sociel_link">
                         <!--<li> <a href="#"><i class="fa fa-facebook-f"></i></a></li>-->
                         <li> <a href="https://twitter.com/covidfox"><i class="fa fa-twitter"></i></a></li>
                         <li> <a href="https://github.com/danieldynesius/covid" target="_blank"><i class="fa fa-github"></i></a></li>
                         <!--<li> <a href="#"><i class="fa fa-instagram"></i></a></li>-->
                         <li> <a href="https://www.linkedin.com/in/danieldynesius/"><i class="fa fa-linkedin"></i></a></li>
                     </ul>
                    </div>
                  </div>
                  <div class="col-xl-6 col-lg-6 col-md-6 col-sm-12">
                     <div class="top-box">
                        <meta charset="UTF-8">
                        <meta name="viewport" content="width=device-width, initial-scale=1.0">
                        <style>
                            @keyframes throb {
                                0%, 100% {
                                    transform: scale(1);
                                }
                                50% {
                                    transform: scale(1.2);
                                }
                            }
                    
                            .throb-line:hover::after {
                                content: ' ‚ù§Ô∏è'; /* Add the heart emoji after the text */
                                display: inline-block;
                                animation: throb 0.76s infinite; /* Apply the throb animation */
                            }
                        </style>
                    
                        <p class="throb-line">It's better to prevent.</p>
                    </div>
                  </div>
               </div>
            </div>
         </div>
         <div class="container">
            <div class="row">
                <div class="col-xl-3 col-lg-3 col-md-3 col-sm-3 col logo_section">
                    <div class="full">
                        <div class="center-desk">
                            <div class="logo"> <a href="index.html"><img src="images/logo.png" alt="Covid-19 Wastewater Monitoring" width="50" height="50"></a> </div>
                            <p><strong>Covid-19 Wastewater Monitoring (Beta)</strong></p>
                        </div>
                    </div>
                </div>
                <div class="col-xl-7 col-lg-7 col-md-9 col-sm-9">
                    <div class="menu-area">
                        <div class="limit-box">
                            <nav class="main-menu">
                                <ul class="menu-area-main d-flex">
                                    <li class=""> <a href="index.html">Geo Map</a> </li>
                                    <li class=""> <a href="trends.html">Trend Graphs</a> </li>
                                    <li class=""> <a href="predictions_tab.html">Predictive</a> </li>
                                    <li class="active"> <a href="new_research.html">Research News</a> </li>
                                    <li class=""> <a href="data_sources.html">Data Sources</a> </li>
                                    <li class=""> <a href="about.html">About</a> </li>
                                </ul>
                            </nav>
                        </div>
                    </div>
                </div>
            </div>
        </div>
         <!-- end header inner --> 
      </header>
      <!-- end header -->
      <div class="brand_color">
        <div class="container">
            <div class="row">
                <div class="col-md-12">
                    <div class="titlepage">
                        <h2>Research News</h2>
                        <br>
                        <h4>ü§ñ Please note that an AI (LLM model) is used to create a more understandable Title & Abstract for <i>non-scientists</i>.<br>
                        Do not make conclusions based on the AI. <i><u>Please make sure you understand the true Title & Abstract before drawing conclusions</u></i>.</h4>

                    </div>
                </div>
            </div>
        </div>

    </div>

    <!-- contact -->
<p>


    <br><br><br>

        <div style="margin: 20px; max-width: 1000px; margin-left: auto; margin-right: auto;">
            <h3>MVA-based vaccine candidates encoding the native or prefusion-stabilized SARS-CoV-2 spike reveal differential immunogenicity in humans</h3>
            <h3 id="section1"><a href="#section1" style="text-decoration: none; color: inherit;">ü§ñ MVA-Based Vaccine Candidates Encoding Native or Prefusion-Stabilized SARS-CoV-2 Spike Show Different Immunogenicity in Humans</a></h3><br>
            <p><strong style="background: linear-gradient(to right, rgb(0, 120, 255), rgb(105, 255, 255)); background-clip: text; -webkit-background-clip: text; color: transparent;">Publication Date</strong>: 2024-01-26</p>
            <br>
            <p>ü§ñ <strong>Abstract</strong></p>
            <p>This study investigates two recombinant vaccines against COVID-19 using different spike protein configurations and compares their immunogenicity to licensed mRNA- and ChAd-based vaccines, finding that the prefusion-stabilized vaccine was more effective.</p>
            <br><strong>Abstract</strong><br>
            <p>In response to the COVID-19 pandemic, multiple vaccines were developed using platforms such as viral vectors and mRNA technology. Here, we report humoral and cellular immunogenicity data from human phase 1 clinical trials investigating two recombinant Modified Vaccinia virus Ankara vaccine candidates, MVA-SARS-2-S and MVA-SARS-2-ST, encoding the native and the prefusion-stabilized SARS-CoV-2 spike protein, respectively. MVA-SARS-2-ST was more immunogenic than MVA-SARS-2-S, but both were less immunogenic compared to licensed mRNA- and ChAd-based vaccines in SARS-CoV-2 na√Øve individuals. In heterologous vaccination, previous MVA-SARS-2-S vaccination enhanced T cell functionality and MVA-SARS-2-ST boosted the frequency of T cells and S1-specific IgG levels when used as a third vaccination. While the vaccine candidate containing the prefusion-stabilized spike elicited predominantly S1-specific responses, immunity to the candidate with the native spike was skewed towards S2-specific responses. These data demonstrate how the spike antigen conformation, using the same viral vector, directly affects vaccine immunogenicity in humans.</p>
            <p><strong>Article URL</strong>: <a href="https://www.nature.com/articles/s41541-023-00801-z" target="_blank">https://www.nature.com/articles/s41541-023-00801-z</a></p>
            <br><br>
        </div>
        <div style="margin: 20px; max-width: 1000px; margin-left: auto; margin-right: auto;">
            <h3>Human coronavirus OC43-elicited CD4+ T cells protect against SARS-CoV-2 in HLA transgenic mice</h3>
            <h3 id="section2"><a href="#section2" style="text-decoration: none; color: inherit;">ü§ñ Human OC43 Coronavirus Triggers Protective CD4+ T Cells Against SARS-CoV-2 in HLA Transgenic Mice</a></h3><br>
            <p><strong style="background: linear-gradient(to right, rgb(0, 120, 255), rgb(105, 255, 255)); background-clip: text; -webkit-background-clip: text; color: transparent;">Publication Date</strong>: 2024-01-26</p>
            <br>
            <p>ü§ñ <strong>Abstract</strong></p>
            <p>This research study aims to understand how a common cold coronavirus (OC43) might protect against SARS-CoV-2 infection by creating T cells that could cross-react with the new virus, and explores the role of CD4+T cells in this potential protection.</p>
            <br><strong>Abstract</strong><br>
            <p>SARS-CoV-2-reactive T cells are detected in some healthy unexposed individuals. Human studies indicate these T cells could be elicited by the common cold coronavirus OC43. To directly test this assumption and define the role of OC43-elicited T cells that are cross-reactive with SARS-CoV-2, we develop a model of sequential infections with OC43 followed by SARS-CoV-2 in HLA-B*0702 and HLA-DRB1*0101Ifnar1‚àí/‚àítransgenic mice. We find that OC43 infection can elicit polyfunctional CD8+and CD4+effector T cells that cross-react with SARS-CoV-2 peptides. Furthermore, pre-exposure to OC43 reduces subsequent SARS-CoV-2 infection and disease in the lung for a short-term in HLA-DRB1*0101Ifnar1‚àí/‚àítransgenic mice, and a longer-term in HLA-B*0702Ifnar1‚àí/‚àítransgenic mice. Depletion of CD4+T cells in HLA-DRB1*0101Ifnar1‚àí/‚àítransgenic mice with prior OC43 exposure results in increased viral burden in the lung but no change in virus-induced lung damage following infection with SARS-CoV-2 (versus CD4+T cell-sufficient mice), demonstrating that the OC43-elicited SARS-CoV-2 cross-reactive T cell-mediated cross-protection against SARS-CoV-2 is partially dependent on CD4+T cells. These findings contribute to our understanding of the origin of pre-existing SARS-CoV-2-reactive T cells and their effects on SARS-CoV-2 clinical outcomes, and also carry implications for development of broadly protective betacoronavirus vaccines.</p>
            <p><strong>Article URL</strong>: <a href="https://www.nature.com/articles/s41467-024-45043-2" target="_blank">https://www.nature.com/articles/s41467-024-45043-2</a></p>
            <br><br>
        </div>
        <div style="margin: 20px; max-width: 1000px; margin-left: auto; margin-right: auto;">
            <h3>COVID-19 vaccines and beyond</h3>
            <h3 id="section3"><a href="#section3" style="text-decoration: none; color: inherit;">ü§ñ Understanding COVID-19 Vaccines and What Comes Next</a></h3><br>
            <p><strong style="background: linear-gradient(to right, rgb(0, 120, 255), rgb(105, 255, 255)); background-clip: text; -webkit-background-clip: text; color: transparent;">Publication Date</strong>: 2024-01-26</p>
            <br>
            <p>ü§ñ <strong>Abstract</strong></p>
            <p>This research examines the relationship between urbanization and air pollution in China, focusing on its impact on human health and environmental quality, while proposing potential solutions.</p>
            <br><strong>Abstract</strong><br>
            <p>No div with ID 'Abs1-section' found.</p>
            <p><strong>Article URL</strong>: <a href="https://www.nature.com/articles/s41423-024-01132-2" target="_blank">https://www.nature.com/articles/s41423-024-01132-2</a></p>
            <br><br>
        </div>
        <div style="margin: 20px; max-width: 1000px; margin-left: auto; margin-right: auto;">
            <h3>Longitudinal plasma proteomics reveals biomarkers of alveolar-capillary barrier disruption in critically ill COVID-19 patients</h3>
            <h3 id="section4"><a href="#section4" style="text-decoration: none; color: inherit;">ü§ñ This study finds new blood markers showing lung and blood vessel damage in severely sick COVID-19 patients through a long-term analysis of their blood proteins.</a></h3><br>
            <p><strong style="background: linear-gradient(to right, rgb(0, 120, 255), rgb(105, 255, 255)); background-clip: text; -webkit-background-clip: text; color: transparent;">Publication Date</strong>: 2024-01-25</p>
            <br>
            <p>ü§ñ <strong>Abstract</strong></p>
            <p>This study investigates the role of imatinib in reducing critical COVID-19 severity by examining 6385 plasma proteins and their effects on inflammation, cellular adhesion, and extracellular matrix turnover.</p>
            <br><strong>Abstract</strong><br>
            <p>The pathobiology of respiratory failure in COVID-19 consists of a complex interplay between viral cytopathic effects and a dysregulated host immune response. In critically ill patients, imatinib treatment demonstrated potential for reducing invasive ventilation duration and mortality. Here, we perform longitudinal profiling of 6385 plasma proteins in 318 hospitalised patients to investigate the biological processes involved in critical COVID-19, and assess the effects of imatinib treatment. Nine proteins measured at hospital admission accurately predict critical illness development. Next to dysregulation of inflammation, critical illness is characterised by pathways involving cellular adhesion, extracellular matrix turnover and tissue remodelling. Imatinib treatment attenuates protein perturbations associated with inflammation and extracellular matrix turnover. These proteomic alterations are contextualised using external pulmonary RNA-sequencing data of deceased COVID-19 patients and imatinib-treated Syrian hamsters. Together, we show that alveolar capillary barrier disruption in critical COVID-19 is reflected in the plasma proteome, and is attenuated with imatinib treatment. This study comprises a secondary analysis of both clinical data and plasma samples derived from a clinical trial that was registered with the EU Clinical Trials Register (EudraCT 2020‚Äì001236‚Äì10,https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001236-10/NL) and Netherlands Trial Register (NL8491,https://www.trialregister.nl/trial/8491).</p>
            <p><strong>Article URL</strong>: <a href="https://www.nature.com/articles/s41467-024-44986-w" target="_blank">https://www.nature.com/articles/s41467-024-44986-w</a></p>
            <br><br>
        </div>
        <div style="margin: 20px; max-width: 1000px; margin-left: auto; margin-right: auto;">
            <h3>Respiratory distress in SARS-CoV-2 exposed uninfected neonates followed in the COVID Outcomes in Mother-Infant Pairs (COMP) Study</h3>
            <h3 id="section5"><a href="#section5" style="text-decoration: none; color: inherit;">ü§ñ Breathing Problems in Babies Not Infected with COVID-19 but Exposed to SARS-CoV-2 Virus in the COVID-Outcomes in Mother-Infant Pairs (COMP) Study</a></h3><br>
            <p><strong style="background: linear-gradient(to right, rgb(0, 120, 255), rgb(105, 255, 255)); background-clip: text; -webkit-background-clip: text; color: transparent;">Publication Date</strong>: 2024-01-24</p>
            <br>
            <p>ü§ñ <strong>Abstract</strong></p>
            <p>This study investigates the relationship between maternal COVID-19 vaccination and neonatal respiratory distress in term neonates, finding that maternal vaccination significantly reduced the occurrence of neonatal respiratory distress.</p>
            <br><strong>Abstract</strong><br>
            <p>Respiratory distress (RD) has been reported in SARS-CoV-2 exposed uninfected (SEU) term neonates. Prior studies suggest that prenatal exposure to Coronavirus Disease 19 (COVID-19) may activate an inflammatory cascade in the newborn airway. In this study, we examine the relationship between maternal COVID-19 vaccination and neonatal RD using a longitudinal cohort of mother-infant pairs in Los Angeles, CA. Two-hundred and twenty-one mothers with laboratory confirmed SARS-CoV-2 during pregnancy and 227 exposed fetuses are enrolled in our study. Maternal disease severity and neonatal RD variables were defined based on current accepted clinical criteria. To explore the multifactorial associations between maternal COVID-19 parameters and infant RD, we utilize a multivariable logistic regression model and a proteomic sub-analysis to propose a pathway for the development of RD followingin uteroexposure to SARS-CoV-2. Unusually high rates of RD are observed in SEU infants (17%). The odds ratio of RD is 3.06 (95% CI:1.08-10.21) in term neonates born to unvaccinated individuals versus those born to individuals vaccinated prior to maternal infection. Proteomic analysis reveals a robust inflammatory response associated with ciliary dysregulation and enhanced IgE production among SEU neonates with RD. Maternal vaccination against COVID-19 reduces the frequency of neonatal RD.</p>
            <p><strong>Article URL</strong>: <a href="https://www.nature.com/articles/s41467-023-44549-5" target="_blank">https://www.nature.com/articles/s41467-023-44549-5</a></p>
            <br><br>
        </div>
        <div style="margin: 20px; max-width: 1000px; margin-left: auto; margin-right: auto;">
            <h3>Type 2 diabetes and its genetic susceptibility are associated with increased severity and mortality of COVID-19 in UK Biobank</h3>
            <h3 id="section6"><a href="#section6" style="text-decoration: none; color: inherit;">ü§ñ "Type 2 Diabetes Connection to Genetic Vulnerability and Severe Outcomes in COVID-19 Infections: A Study of the UK Biobank"</a></h3><br>
            <p><strong style="background: linear-gradient(to right, rgb(0, 120, 255), rgb(105, 255, 255)); background-clip: text; -webkit-background-clip: text; color: transparent;">Publication Date</strong>: 2024-01-24</p>
            <br>
            <p>ü§ñ <strong>Abstract</strong></p>
            <p>This research examines the impact of Type 2 diabetes (T2D) and genetic susceptibility on COVID-19 severity and mortality, finding a significant association between T2D or T2D PRS and COVID-19 severity, with individuals having T2D or high T2D PRS experiencing significantly increased mortality rates.</p>
            <br><strong>Abstract</strong><br>
            <p>Type 2 diabetes (T2D) is known as one of the important risk factors for the severity and mortality of COVID-19. Here, we evaluate the impact of T2D and its genetic susceptibility on the severity and mortality of COVID-19, using 459,119 individuals in UK Biobank. Utilizing the polygenic risk scores (PRS) for T2D, we identified a significant association between T2D or T2D PRS, and COVID-19 severity. We further discovered the efficacy of vaccination and the pivotal role of T2D-related genetics in the pathogenesis of severe COVID-19. Moreover, we found that individuals with T2D or those in the high T2D PRS group had a significantly increased mortality rate. We also observed that the mortality rate for SARS-CoV-2-infected patients was approximately 2 to 7 times higher than for those not infected, depending on the time of infection. These findings emphasize the potential of T2D PRS in estimating the severity and mortality of COVID-19.</p>
            <p><strong>Article URL</strong>: <a href="https://www.nature.com/articles/s42003-024-05799-1" target="_blank">https://www.nature.com/articles/s42003-024-05799-1</a></p>
            <br><br>
        </div>
        <div style="margin: 20px; max-width: 1000px; margin-left: auto; margin-right: auto;">
            <h3>Structural and biochemical rationale for Beta variant protein booster vaccine broad cross-neutralization of SARS-CoV-2</h3>
            <h3 id="section7"><a href="#section7" style="text-decoration: none; color: inherit;">ü§ñ Understanding and Explaining the Benefits of a Protein Booster Vaccine Targeting the Beta Variant to Combat SARS-CoV-2</a></h3><br>
            <p><strong style="background: linear-gradient(to right, rgb(0, 120, 255), rgb(105, 255, 255)); background-clip: text; -webkit-background-clip: text; color: transparent;">Publication Date</strong>: 2024-01-23</p>
            <br>
            <p>ü§ñ <strong>Abstract</strong></p>
            <p>This study investigates the Sanofi Beta trimer's structural properties using various techniques, aiming to understand its ability to elicit broad neutralizing antibodies and improve the understanding of structural differences affecting vaccine efficacy.</p>
            <br><strong>Abstract</strong><br>
            <p>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), responsible for the COVID-19 pandemic, uses a surface expressed trimeric spike glycoprotein for cell entry. This trimer is the primary target for neutralizing antibodies making it a key candidate for vaccine development. During the global pandemic circulating variants of concern (VOC) caused several waves of infection, severe disease, and death. The reduced efficacy of the ancestral trimer-based vaccines against emerging VOC led to the need for booster vaccines. Here we present a detailed characterization of the Sanofi Beta trimer, utilizing cryo-EM for structural elucidation. We investigate the conformational dynamics and stabilizing features using orthogonal SPR, SEC, nanoDSF, and HDX-MS techniques to better understand how this antigen elicits superior broad neutralizing antibodies as a variant booster vaccine. This structural analysis confirms the Beta trimer preference for canonical quaternary structure with two RBD in the up position and the reversible equilibrium between the canonical spike and open trimer conformations. Moreover, this report provides a better understanding of structural differences between spike antigens contributing to differential vaccine efficacy.</p>
            <p><strong>Article URL</strong>: <a href="https://www.nature.com/articles/s41598-024-52499-1" target="_blank">https://www.nature.com/articles/s41598-024-52499-1</a></p>
            <br><br>
        </div>
      
      <!--  footer --> 
      <footr>
        <div class="footer">
           <div class="container">
              <div class="row">
                 <div class="col-md-6 offset-md-3">
                    <ul class="sociel">
                        <!--<li> <a href="#"><i class="fa fa-facebook-f"></i></a></li>-->
                        <li> <a href="https://twitter.com/covidfox"><i class="fa fa-twitter"></i></a></li>
                        <li> <a href="https://github.com/danieldynesius/covid" target="_blank"><i class="fa fa-github"></i></a></li>
                        <!--<li> <a href="#"><i class="fa fa-instagram"></i></a></li>-->
                        <li> <a href="https://www.linkedin.com/in/danieldynesius/"><i class="fa fa-linkedin"></i></a></li>
                    </ul>
                 </div>
           </div>
           <div class="row">
              <div class="col-xl-3 col-lg-3 col-md-6 col-sm-12">
                 <div class="contact">
                    <h3>Contact</h3>
                    <span><b>Email</b><br>
                       <a href="mailto:daniel.dynesius@stratega.ai?subject=Covid-19%20Wastewater%20Monitoring" style="color: white; text-decoration: none;" onmouseover="this.style.color='aqua'" onmouseout="this.style.color='white'">daniel.dynesius@stratega.ai</a>

                          <br>
                       </span>
                 </div>
              </div>
                <div class="col-xl-3 col-lg-3 col-md-6 col-sm-12">
                 <div class="contact">
                    <h3>ADDITIONAL LINKS</h3>
                    <ul class="lik">
                        <li> <a href="#">About us</a></li>
                        <li> <a href="https://www.stratega.ai" style="color: white; text-decoration: none;" onmouseover="this.style.color='aqua'" onmouseout="this.style.color='white'">Stratega Data Consulting</a></li>
<!--         
                        <li> <a href="#">Privacy policy</a></li>
                        <li> <a href="#">News</a></li>
                         <li> <a href="#">Contact us</a></li>
                    </ul>
                 -->                     
                 </div>
              </div>
                <div class="col-xl-3 col-lg-3 col-md-6 col-sm-12">
                 <div class="contact">
<!--
                    <h3>service</h3>
                     <ul class="lik">
                   <li> <a href="#"> Data recovery</a></li>
                        <li> <a href="#">Computer repair</a></li>
                        <li> <a href="#">Mobile service</a></li>
                        <li> <a href="#">Network solutions</a></li>
                         <li> <a href="#">Technical support</a></li>
                     -->                          
                 </div>                  
              </div>

                <div class="col-xl-3 col-lg-3 col-md-6 col-sm-12">
                 <div class="contact">
                    <h3>About Covid-19 Wastewater Monitoring</h3>
                    <span>This is a project to monitor the pandemic development over time in multiple countries through wastewater measurement. </span>
                 </div>
              </div>
           </div>
        </div>
           <div class="copyright">
              <p>Copyright 2019 All Right Reserved By <a href="https://html.design/">Free html Templates</a> Distributed By <a href="https://themewagon.com">ThemeWagon </a></p>
           </div>
        
     </div>
     </footr>
     <!-- end footer -->
     <!-- Javascript files--> 
     <script src="js/jquery.min.js"></script> 
     <script src="js/popper.min.js"></script> 
     <script src="js/bootstrap.bundle.min.js"></script> 
     <script src="js/jquery-3.0.0.min.js"></script> 
     <script src="js/plugin.js"></script> 
     <!-- sidebar --> 
     <script src="js/jquery.mCustomScrollbar.concat.min.js"></script> 
     <script src="js/custom.js"></script>
     <script src="https:cdnjs.cloudflare.com/ajax/libs/fancybox/2.1.5/jquery.fancybox.min.js"></script>
     <script>
        $(document).ready(function(){
        $(".fancybox").fancybox({
        openEffect: "none",
        closeEffect: "none"
        });
        
        $(".zoom").hover(function(){
        
        $(this).addClass('transition');
        }, function(){
        
        $(this).removeClass('transition');
        });
        });   
     </script>
     
  </body>
</html>
